CA2122923A1 - Compositions for regulating skin wrinkles and/or skin atrophy - Google Patents

Compositions for regulating skin wrinkles and/or skin atrophy

Info

Publication number
CA2122923A1
CA2122923A1 CA 2122923 CA2122923A CA2122923A1 CA 2122923 A1 CA2122923 A1 CA 2122923A1 CA 2122923 CA2122923 CA 2122923 CA 2122923 A CA2122923 A CA 2122923A CA 2122923 A1 CA2122923 A1 CA 2122923A1
Authority
CA
Canada
Prior art keywords
skin
compositions
atrophy
regulating
wrinkles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2122923
Other languages
French (fr)
Other versions
CA2122923C (en
Inventor
Roy L. Blank
Carlos G. Linares
Darrell G. Doughty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Roy L. Blank
Carlos G. Linares
Darrell G. Doughty
Richardson-Vicks, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roy L. Blank, Carlos G. Linares, Darrell G. Doughty, Richardson-Vicks, Inc. filed Critical Roy L. Blank
Publication of CA2122923A1 publication Critical patent/CA2122923A1/en
Application granted granted Critical
Publication of CA2122923C publication Critical patent/CA2122923C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Abstract

The present invention relates to a composition for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component.
CA002122923A 1991-11-25 1992-11-09 Compositions for regulating skin wrinkles and/or skin atrophy Expired - Fee Related CA2122923C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79674991A 1991-11-25 1991-11-25
US796749 1991-11-25

Publications (2)

Publication Number Publication Date
CA2122923A1 true CA2122923A1 (en) 1993-06-10
CA2122923C CA2122923C (en) 1999-01-19

Family

ID=25168962

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002122923A Expired - Fee Related CA2122923C (en) 1991-11-25 1992-11-09 Compositions for regulating skin wrinkles and/or skin atrophy

Country Status (9)

Country Link
US (10) US5605894A (en)
EP (1) EP0614353A1 (en)
JP (1) JPH07501540A (en)
CN (1) CN1063627C (en)
AU (1) AU3073692A (en)
CA (1) CA2122923C (en)
MX (1) MX9206765A (en)
PT (1) PT101089A (en)
WO (1) WO1993010755A1 (en)

Families Citing this family (175)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0614353A1 (en) * 1991-11-25 1994-09-14 Richardson-Vicks, Inc. Compositions for regulating skin wrinkles and/or skin atrophy
US5780459A (en) * 1991-11-25 1998-07-14 The Procter & Gamble Company Compositions for regulating skin wrinkles and or skin atrophy
WO1993010756A1 (en) * 1991-11-25 1993-06-10 Richardson-Vicks, Inc. Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
DE4228455A1 (en) * 1992-08-26 1994-09-15 Beiersdorf Ag Cosmetic and dermatological sunscreen formulations containing thiols and / or thiol derivatives
ATE150960T1 (en) * 1992-08-26 1997-04-15 Beiersdorf Ag USE OF RADICAL CATCHERS AS IMMUNOMODULATING AGENTS IN COSMETIC AND DERMATOLOGICAL PREPARATIONS
US5989536A (en) * 1993-07-03 1999-11-23 The Procter & Gamble Company Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin
US6001379A (en) * 1993-09-15 1999-12-14 L'oreal Stable acidic oil-in- water type emulsions and compositions containing them
FR2709982B1 (en) * 1993-09-15 1995-12-08 Oreal Stable acidic oil-in-water emulsions and compositions containing them.
US5681852A (en) * 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
FR2722691A1 (en) 1994-07-22 1996-01-26 Oreal COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTENT COMBATING ACNE OR AGING WITH THERMAL OR MINERAL WATER AND AN ACTIVE INGREDIENT FOR
UA10208A (en) * 1994-08-03 1996-12-25 Жанна Прокопівна Гудзенко Dermatological cosmetic preparation
US5976521A (en) * 1994-08-09 1999-11-02 The Procter & Gamble Company Anti-acne cosmetic compositions
US5472698A (en) * 1994-12-20 1995-12-05 Elizabeth Arden Co., Division Of Conopco, Inc. Composition for enhancing lipid production in skin
FR2728793A1 (en) * 1994-12-28 1996-07-05 Oreal Compsns. for treating sensitive skin
US5645825A (en) * 1995-06-07 1997-07-08 The Procter & Gamble Company Depilatory compositions comprising sulfhydryl compounds
US6221911B1 (en) 1995-06-07 2001-04-24 Karo Bio Ab Uses for thyroid hormone compounds or thyroid hormone-like compounds
US6380255B1 (en) 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
US6238678B1 (en) 1995-11-06 2001-05-29 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
AU721214B2 (en) 1996-02-08 2000-06-29 Albert M. Kligman Composition and method for effecting superficial chemical skin peels
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
WO1997044008A1 (en) * 1996-05-21 1997-11-27 Derma Sciences, Inc. Topical barrier composition containing silicone and bentonite
US5891451A (en) * 1996-06-25 1999-04-06 Elizabeth Arden Company, Division Of Conopco, Inc. Skin treatment with salicylic acid esters
US5741497A (en) * 1996-06-25 1998-04-21 Elizabeth Arden Company Skin treatment with salicylic acid esters
NL1003992C2 (en) * 1996-09-10 1998-03-11 Stein Gerrit Cornelis Johan Therapeutic gel composition for skin treatment
US5773015A (en) * 1996-11-27 1998-06-30 Elizabeth Arden Co., Division Of Conopco, Inc. Method for controlling skin oils and grease
US5728732A (en) * 1996-11-27 1998-03-17 Elizabeth Arden Company, Division Of Conopco, Inc. Skin treatment with salicylic acid esters and retinoids
FR2758083B1 (en) * 1997-01-03 1999-02-05 Oreal COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTAINING A DISPERSION OF A POLYMERIC SYSTEM AND USE OF THE SYSTEM AS A TENSIONER
US5762947A (en) * 1997-05-09 1998-06-09 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic skin conditioning compositions containing a salicyloxy α-carboxy acid
TWI234467B (en) 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
EP0969793B1 (en) * 1997-12-05 2004-06-30 Wella Aktiengesellschaft Use of a foil for wrapping hair ends before permanent wave treatment and said foils.
US6159480A (en) * 1997-12-15 2000-12-12 Neostrata Company, Inc. Cosmetic makeup composition
US6068848A (en) * 1997-12-17 2000-05-30 Color Access, Inc. Antioxidant mixture comprising tocopherol
US6066327A (en) * 1997-12-17 2000-05-23 Color Access, Inc. Antioxidant mixture
FR2772610B1 (en) * 1997-12-19 2006-06-02 Oreal USE OF CINNAMIC ACID OR AT LEAST ONE OF ITS DERIVATIVES IN A COSMETIC COMPOSITION
US6660283B2 (en) 1997-12-19 2003-12-09 Societe L'oreal S.A. Use of cinnamic acid, or of at least one of its derivatives in a cosmetic composition
FR2772612B1 (en) * 1997-12-19 2003-01-10 Oreal USE OF CINNAMIC ACID OR DERIVATIVES THEREOF IN A FIRMING COSMETIC COMPOSITION
US6022548A (en) * 1998-03-26 2000-02-08 Elizabeth Arden Co. Cosmetic skin conditioning compositions containing methoxycinnamyloxy salicylate
US8106094B2 (en) * 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8093293B2 (en) * 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US20020197244A1 (en) * 1998-12-07 2002-12-26 Miri Seiberg Compositions and methods for regulating phagocytosis and ICAM-1 expression
EP1038793B1 (en) 1999-03-19 2005-10-26 The Procter & Gamble Company Article comprising a cell system
EP1038794A1 (en) 1999-03-19 2000-09-27 The Procter & Gamble Company An article comprising a cell system
EP1038792A1 (en) 1999-03-19 2000-09-27 The Procter & Gamble Company Improved packaged article
US6372230B1 (en) * 1999-04-28 2002-04-16 Nick Joseph Schincaglia Skin care composition, its use and apparatus for the application thereof
US20040228887A1 (en) * 1999-05-11 2004-11-18 Champ Charles W. Host-guest processes and formulations for delivering bio-affecting compounds
US7268148B2 (en) * 1999-05-20 2007-09-11 Regents Of The University Of Michigan Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
US20040235950A1 (en) * 1999-05-20 2004-11-25 Voorhees John J. Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
JP2003522734A (en) * 1999-06-25 2003-07-29 アーチ ケミカルズ，インコーポレイテッド Pyrithione biocides enhanced by silver, copper, or zinc ions
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
AU5838700A (en) 1999-07-30 2001-02-19 Procter & Gamble Company, The Method for treating and preventing finger disorders
US6479058B1 (en) * 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
US6358517B1 (en) * 1999-10-22 2002-03-19 Unilever Home & Personal Care Usa, Division Of Conopco Cosmetic compositions containing resveratrol and retinoids
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US6355261B1 (en) 1999-12-02 2002-03-12 The C. P. Hall Company Ultraviolet radiation absorbing waxes useful in cosmetic compositions
US6632429B1 (en) * 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US7557235B2 (en) 2000-02-16 2009-07-07 Lubrizol Advanced Materials, Inc. Hydroxyl-terminated thiocarbonate containing compounds, polymers, and copolymers, and polyurethanes and urethane acrylics made therefrom
GB0004686D0 (en) * 2000-02-28 2000-04-19 Aventis Pharma Ltd Chemical compounds
US6585984B1 (en) * 2000-03-03 2003-07-01 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Dual composition cosmetic product with a concentration sensitive and an incompatible active respectively placed within first and second compositions
JP2001316294A (en) * 2000-03-14 2001-11-13 Pfizer Prod Inc Method for using o-vanillin and compound combination of o-vanillin and tetramethylchromanyl carboxylic acid
US6403108B1 (en) 2000-03-31 2002-06-11 Sheikh Ahmed Abdullah Cosmetic composition and method of use
US7674785B2 (en) * 2000-06-22 2010-03-09 The Procter & Gamble Company Topical anti-microbial compositions
US6576702B2 (en) 2000-07-20 2003-06-10 Noveon Ip Holdings Corp. Plasticized waterborne polyurethane dispersions and manufacturing process
US20070053895A1 (en) * 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8431550B2 (en) * 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US8030002B2 (en) * 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US20020142016A1 (en) * 2000-12-28 2002-10-03 Granger Stewart Paton Stable skin care product containing a retinoid and a retinoid booster system in a dual compartment package
US7192615B2 (en) * 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
FR2821550B1 (en) * 2001-03-05 2004-04-23 Oreal ANTI-WRINKLE COMPOSITION COMPRISING A POLYAMINOACID DERIVATIVE, AND USE OF THIS COMPOUND FOR THE FIGHT AGAINST WRINKLE OF THE SKIN
WO2002087692A1 (en) * 2001-04-26 2002-11-07 The Procter & Gamble Company A method and apparatus for the treatment of cosmetic skin conditioins
WO2002096374A2 (en) 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
EP1432399A1 (en) * 2001-10-04 2004-06-30 Unilever Plc Enhancing epidermal barrier development in skin
DK1448772T3 (en) * 2001-11-30 2007-11-19 Serono Lab Methods for increasing expression levels of human TNF receptor
US20030224075A1 (en) * 2002-02-21 2003-12-04 Jue-Chen Liu Soy composition for balancing combination skin
US7358295B2 (en) * 2002-04-05 2008-04-15 Lubrizol Advanced Materials, Inc. Hybrid polymer composition, and article therefrom
US6897281B2 (en) * 2002-04-05 2005-05-24 Noveon Ip Holdings Corp. Breathable polyurethanes, blends, and articles
WO2003088965A1 (en) * 2002-04-22 2003-10-30 The Procter & Gamble Company Use of materials having zinc ionophoric behavior
JP3851312B2 (en) * 2002-04-22 2006-11-29 ザ プロクター アンド ギャンブル カンパニー Personal care composition comprising a zinc-containing material in an aqueous surfactant composition
US8100844B2 (en) * 2002-04-25 2012-01-24 Ultraflex Systems, Inc. Ambulating ankle and knee joints with bidirectional dampening and assistance using elastomeric restraint
US8491877B2 (en) * 2003-03-18 2013-07-23 The Procter & Gamble Company Composition comprising zinc-containing layered material with a high relative zinc lability
US9381382B2 (en) 2002-06-04 2016-07-05 The Procter & Gamble Company Composition comprising a particulate zinc material, a pyrithione or a polyvalent metal salt of a pyrithione and a gel network
US9381148B2 (en) * 2003-03-18 2016-07-05 The Procter & Gamble Company Composition comprising particulate zinc material with a high relative zinc lability
US20050202984A1 (en) * 2003-03-18 2005-09-15 Schwartz James R. Composition comprising zinc-containing layered material with a high relative zinc lability
US20050209428A1 (en) * 2002-06-19 2005-09-22 Krishnan Tamareselvy Breathable polyurethanes, blends, and articles
US20040241130A1 (en) * 2002-09-13 2004-12-02 Krishnan Tamareselvy Multi-purpose polymers, methods and compositions
US7378479B2 (en) * 2002-09-13 2008-05-27 Lubrizol Advanced Materials, Inc. Multi-purpose polymers, methods and compositions
US20040063593A1 (en) * 2002-09-30 2004-04-01 Wu Jeffrey M. Compositions containing a cosmetically active organic acid and a legume product
US20040131700A1 (en) * 2002-10-25 2004-07-08 Essentia Biosystems, Inc. Implantable medical devices using zinc
US7479507B2 (en) * 2003-01-14 2009-01-20 Adam Heller Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs
US6878221B1 (en) 2003-01-30 2005-04-12 Olin Corporation Lead-free nontoxic explosive mix
US20040213751A1 (en) * 2003-03-18 2004-10-28 Schwartz James Robert Augmentation of pyrithione activity or a polyvalent metal salt of pyrithione activity by zinc-containing layered material
US20040191331A1 (en) * 2003-03-18 2004-09-30 The Procter & Gamble Company Composition comprising particulate zinc materials having a defined crystallite size
US20050004561A1 (en) * 2003-07-01 2005-01-06 Lynn Halas Method for removing hair
US20070155462A1 (en) * 2003-07-22 2007-07-05 O'halloran Terry Side bets in casino wagering "war" game
US20050036976A1 (en) * 2003-08-12 2005-02-17 Joel Rubin Topical skin care composition
WO2005048969A1 (en) * 2003-10-29 2005-06-02 Johnson & Johnson Consumer France S.A.S. Compositions comprising soy products and dioic acids
CA2545788A1 (en) * 2003-11-13 2005-06-02 Galileo Pharmaceuticals, Inc. Plant-derived protein extract compositions and methods
US20050147570A1 (en) * 2004-01-06 2005-07-07 Nordsiek Michael T. Methods of administering diclofenac compositions for treating photodamaged skin, rosacea and/or acne
US20080253960A1 (en) * 2004-04-01 2008-10-16 The Trustees Of The University Of Pennsylvania Center For Technology Transfer Lipoprotein-Based Nanoplatforms
EP1786848A1 (en) 2004-08-06 2007-05-23 Noveon, Inc. Polyurethanes and urethane acrylics made from hydroxyl-terminated thiocarbonate containing compounds
US8137754B2 (en) * 2004-08-06 2012-03-20 Lubrizol Advanced Materials, Inc. Hydroxyl-terminated thiocarbonate containing compounds, polymers, and copolymers, and polyurethanes and urethane acrylics made therefrom
PT1791791T (en) * 2004-09-27 2019-09-12 Special Water Patents B V Methods and compositions for treatment of water
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
WO2006081071A1 (en) * 2005-01-26 2006-08-03 The Procter & Gamble Company Low ph skin care compositions containing dehydroacetic acid
US20060194759A1 (en) * 2005-02-25 2006-08-31 Eidelson Stewart G Topical compositions and methods for treating pain and inflammation
US8563491B2 (en) * 2005-03-04 2013-10-22 The Procter & Gamble Company Methods of cleansing skin and rinse-off or wipe-off compositions therefor
BRPI0613321A2 (en) * 2005-06-03 2011-01-04 Horizon Science Pty Ltd drug delivery system for a bioactive powder, chocolate product having a uniform distribution of a bioactive powder comprising the drug delivery system, method for the distribution of bioactive powders, use of a lipid, cocoa product having a uniform distribution of a bioactive powder, method for the manufacture of a chocolate product comprising a bioactive powder, method for improving the bioavailability of a lipophilic bioactive powder, method for minimizing the level of degradation of a bioactive powder, method for incorporating bioactive substances in cocoa products, chocolate in wine product, method for enhancing the absorption of a polyphenol in a human's blood and method for promoting a human's vascular health
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
CA2623725A1 (en) * 2005-09-30 2007-04-12 Omp, Inc. Stable ascorbic acid compositions
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
KR20090004980A (en) * 2006-04-18 2009-01-12 디에스엠 아이피 어셋츠 비.브이. Cosmetic compositions comprising salicylic acid and ascorbic acid
US20080008818A1 (en) * 2006-06-23 2008-01-10 Miri Seiberg Partially denatured whole soybean extracts and methods of use thereof
US7723387B2 (en) * 2006-06-28 2010-05-25 Polymer Surfaces Group, Llc Self-neutralizing acid peel for dermatologic use
US20080026074A1 (en) * 2006-07-27 2008-01-31 Hannah Naomi Sivak Method of short term skin wrinkles correction using strontium divalent ion
DE102006038471A1 (en) * 2006-08-17 2008-04-10 Wala-Heilmittel Gmbh Sycamore cream, process for its preparation and use
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
US20080089960A1 (en) * 2006-10-16 2008-04-17 Miri Seiberg Use of Legume Products for the Treatment and Prevention of Radiotherapy-Induced Skin Damage
US20080139518A1 (en) * 2006-12-04 2008-06-12 Concert, Llc Topical compositions for treatment of skin conditions
US8178113B2 (en) * 2007-04-02 2012-05-15 Sheikh Ahmed Abdullah Cosmetic composition and methods of use
CA2684998A1 (en) 2007-04-30 2009-01-29 Nanogen, Inc. Multianalyte assay
US20110020242A1 (en) 2007-12-12 2011-01-27 Gang Zheng High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
MX2010010668A (en) * 2008-03-28 2011-04-26 Nu Skin International Inc Compositions comprising anrnox-inhibitors for the inhibition of reactive oxygen species.
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
ES2327201B1 (en) * 2008-04-23 2010-07-23 Ignacio Umbert Millet PERSONALIZED PHARMACEUTICAL COMPOSITION FOR THE REJUVENATION OF SKIN CONTAINING RETINOIC ACID.
US9320780B2 (en) * 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US20090324730A1 (en) * 2008-06-26 2009-12-31 Fallon Joan M Methods and compositions for the treatment of symptoms of complex regional pain syndrome
EP2318035B1 (en) * 2008-07-01 2019-06-12 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US9000033B2 (en) * 2008-07-31 2015-04-07 Arch Personal Care Products, L.P. Composition for improving skin condition and appearance
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
IT1394921B1 (en) * 2008-11-10 2012-07-27 Giuliani Spa USE OF COMPOUNDS AS ACTIVE PRINCIPLES TO IMPROVE THE CELL REPAIR ACTION OF THE HUMAN EPIDERMISAL, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS THAT CONTAIN THEM
EP3064217B1 (en) 2009-01-06 2018-04-18 Galenagen, LLC Compositions comprising protease, amylase and lipase for use in the treatment of staphylococcus aureus infections
US9084784B2 (en) 2009-01-06 2015-07-21 Curelon Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
EP2545600A2 (en) 2010-03-11 2013-01-16 Merck Patent GmbH Radiative fibers
JP6246468B2 (en) 2010-03-11 2017-12-13 メルク パテント ゲーエムベーハー Fiber in therapy and cosmetics
EP2563356A4 (en) * 2010-04-27 2013-10-16 St John S Medical Res Inst A composition for skin sanitization and protection and method of its use
US20130226268A1 (en) 2010-07-26 2013-08-29 Merck Patent Gmbh Nanocrystals in devices
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
WO2012110178A1 (en) 2011-02-14 2012-08-23 Merck Patent Gmbh Device and method for treatment of cells and cell tissue
EP2691073B1 (en) 2011-03-27 2017-05-31 Arch Chemicals, Inc. Modulating epigenetic dna methylation to cause cells to adopt dna methylation patterns associated with young cells
US9744381B2 (en) 2011-03-30 2017-08-29 Arch Chemicals, Inc. Topical compositions and methods for influencing electromagnetic radiation on cutaneous extracellular matrix protein production
CN103619348B (en) 2011-04-21 2016-10-26 柯尔马克有限责任公司 For treating the compound of neuropsychiatric disorders
JP5789426B2 (en) * 2011-06-17 2015-10-07 エスエス製薬株式会社 Epidermis turnover accelerator
WO2013060771A2 (en) 2011-10-25 2013-05-02 Arch Personal Care Products, L.P. Composition containing an extract of a sequential or simultaneous fermentation
US20130164234A1 (en) 2011-12-22 2013-06-27 Lonza Walkersville, Inc. Composition for treating skin pigmentation
KR20140123555A (en) 2012-01-30 2014-10-22 메르크 파텐트 게엠베하 Nanocrystals on fibers
TW201336520A (en) * 2012-03-05 2013-09-16 Otsuka Pharma Co Ltd Sunscreen composition
FR2987741B1 (en) * 2012-03-08 2014-04-18 Capsum KIT COMPRISING TWO SEPARATE COMPOSITIONS, IN PARTICULAR FOR A COSMETIC APPLICATION
EP2664919A1 (en) * 2012-05-15 2013-11-20 Jean Hilaire Saurat A method for identifying the AhR receptor ligands having a therapeutic sebosuppressive activity
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US8758731B2 (en) 2012-06-29 2014-06-24 Johnson & Johnson Consumer Companies, Inc. Skin lightening by topical application of 1-hydroxyl 3,5-bis(4′hydroxyl styryl)benzene
US8846013B2 (en) 2012-06-29 2014-09-30 Johnson & Johnson Consumer Companies, Inc. Topical application of 1-hydroxyl-3,5-BIS(4′hydroxy styryl)benzene
CN103284928A (en) * 2013-07-02 2013-09-11 孙佳丽 Medicine for shrinking enlarged pores by utilizing egg white and preparation method thereof
KR102559195B1 (en) 2013-08-15 2023-07-24 마리 케이 인코포레이티드 Topical skin compositions for treating wrinkles
FR3013218B1 (en) * 2013-11-18 2016-07-29 Capsum COMPOSITION COMPRISING BUFFER-STABILIZED GELIFIED CAPSULES
CN105416811B (en) 2014-09-16 2017-11-07 安杰拉专利有限责任公司 Closed-system and associated vessel and implementation method for container
CN109069473B (en) 2016-04-21 2022-09-16 港大科桥有限公司 Compositions and methods for lightening skin and reducing hyperpigmentation
JPWO2019171843A1 (en) * 2018-03-05 2021-02-25 パナソニックＩｐマネジメント株式会社 Cosmetics or medical materials
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
WO2023164487A1 (en) 2022-02-22 2023-08-31 Brown University Compositions and methods to achieve systemic uptake of particles following oral or mucosal administration
WO2023250318A1 (en) 2022-06-20 2023-12-28 Georgia State University Research Foundation, Inc. Compounds and method for upregulation of p53 through induction of mdm2 degradation
US11896691B1 (en) * 2023-01-09 2024-02-13 Julius Zecchino Universal mineral based sunscreen

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821370A (en) * 1971-03-11 1974-06-28 L Tenta Topical composition for treating seborrheic keratosis
JPS5540632A (en) * 1978-09-16 1980-03-22 Nippon Solid Co Ltd Cosmetic pack
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4542129A (en) * 1982-08-16 1985-09-17 Norman Orentreich DHEA Formulations and methods for treating dry skin
DE3579343D1 (en) * 1984-03-07 1990-10-04 Roshdy Ismail AGENTS FOR TREATING AND PROTECTING THE SKIN.
US4888342A (en) * 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US5017367A (en) * 1984-10-01 1991-05-21 Stojkoski Radmila G Skin treatment preparation
US4608370A (en) * 1985-03-04 1986-08-26 Aronsohn Richard B Skin formulation
FR2581542B1 (en) * 1985-05-07 1988-02-19 Oreal TOPICAL COMPOSITIONS FOR THE TREATMENT OF SKIN BASED ON SALICYLIC ACID DERIVATIVES
GB2179858B (en) * 1985-09-04 1989-11-08 Boehringer Ingelheim Int Compositions for treating viral skin diseases.
FR2607498B1 (en) * 1986-12-01 1991-04-05 Oreal NOVEL LIPOPHILIC SALICYLATES OF QUATERNARY AMMONIUMS, THEIR USE IN COSMETICS AND DERMOPHARMACY
ZA879063B (en) * 1986-12-22 1989-04-26 Hoffmann La Roche Use of 13-cis retinoic acid
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US5389677B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
US4800197A (en) * 1987-07-17 1989-01-24 Richardson-Vicks Inc. Anti-acne composition
US4891227A (en) * 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
US4891228A (en) * 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
US5262407A (en) * 1988-12-16 1993-11-16 L'oreal Use of salicylic derivatives for the treatment of skin aging
LU87408A1 (en) * 1988-12-16 1990-07-10 Oreal USE OF SALICYL DERIVATIVES FOR THE TREATMENT OF AGING SKIN
CH679981A5 (en) * 1989-12-21 1992-05-29 Paul Dr Med Herzog
US5380764A (en) * 1989-06-08 1995-01-10 Herzog; Paul Composition of vitamin A, glucose and hydrogen peroxide for cosmetic or pharmaceutical use
US5296476A (en) * 1989-09-08 1994-03-22 Henderson Esther G Skin care compositions
EP0614353A1 (en) * 1991-11-25 1994-09-14 Richardson-Vicks, Inc. Compositions for regulating skin wrinkles and/or skin atrophy
WO1993010756A1 (en) * 1991-11-25 1993-06-10 Richardson-Vicks, Inc. Use of salicylic acid for regulating skin wrinkles and/or skin atrophy

Also Published As

Publication number Publication date
US5789396A (en) 1998-08-04
AU3073692A (en) 1993-06-28
US5605894A (en) 1997-02-25
US5776917A (en) 1998-07-07
PT101089A (en) 1994-02-28
US5776918A (en) 1998-07-07
JPH07501540A (en) 1995-02-16
US5883085A (en) 1999-03-16
CA2122923C (en) 1999-01-19
WO1993010755A1 (en) 1993-06-10
US5804572A (en) 1998-09-08
US5837697A (en) 1998-11-17
CN1073859A (en) 1993-07-07
US5869470A (en) 1999-02-09
CN1063627C (en) 2001-03-28
US5786345A (en) 1998-07-28
EP0614353A1 (en) 1994-09-14
MX9206765A (en) 1993-06-01
US5811413A (en) 1998-09-22

Similar Documents

Publication Publication Date Title
CA2122923A1 (en) Compositions for regulating skin wrinkles and/or skin atrophy
EP0958810A3 (en) Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
CA2116234A1 (en) Use of N-Acetyl-L-Cysteine and Derivatives for Regulating Skin Wrinkles and/or Skin Atrophy
CA2077144A1 (en) Cosmetic Composition
CA2132613A1 (en) Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface
AU1974888A (en) Glycerol and diglycerol mixtures for skin moisturising
PL264392A1 (en) A microbes killing agent
CA2005811A1 (en) Cosmetic composition
CA2088254A1 (en) Treatment for hypercholesterolemia
AU6333794A (en) Retinoid composition
EP0348184A3 (en) Cosmetic composition
CA2061870A1 (en) Medicinal compositions for use as a skin moisturizer and the treatment of exzema
GB9207191D0 (en) Cosmetic compositions
EP0577699A4 (en) Compositions and methods to inhibit the activation of active factor xiii.
EP0089198A3 (en) Nontoxic aspirin-containing composition
IL95101A0 (en) Compositions containing lycd and other topically active ingredients
GB8921163D0 (en) Synergistically active compositions and process for preparing the same
MX9603878A (en) Methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed